Compare ORMP & EVGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ORMP | EVGO |
|---|---|---|
| Founded | 2002 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 197.6M | 195.6M |
| IPO Year | 2010 | 2020 |
| Metric | ORMP | EVGO |
|---|---|---|
| Price | $4.20 | $1.08 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $3.34 |
| AVG Volume (30 Days) | 151.9K | ★ 3.3M |
| Earning Date | 11-12-2026 | 11-09-2026 |
| Dividend Yield | ★ 6.00% | N/A |
| EPS Growth | ★ 412.50 | 24.39 |
| EPS | ★ 2.76 | N/A |
| Revenue | $2,000,000.00 | ★ $54,588,000.00 |
| Revenue This Year | N/A | $6.04 |
| Revenue Next Year | N/A | $28.83 |
| P/E Ratio | $1.51 | ★ N/A |
| Revenue Growth | 49.25 | ★ 145.74 |
| 52 Week Low | $2.09 | $1.07 |
| 52 Week High | $5.47 | $4.73 |
| Indicator | ORMP | EVGO |
|---|---|---|
| Relative Strength Index (RSI) | 35.04 | 30.35 |
| Support Level | $4.16 | N/A |
| Resistance Level | $4.22 | $1.53 |
| Average True Range (ATR) | 0.15 | 0.07 |
| MACD | -0.05 | -0.02 |
| Stochastic Oscillator | 10.26 | 5.41 |
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
EVgo Inc is an EV fast charging provider. The company deploys charging infrastructure by partnering with retailers, grocery stores, restaurants, gas stations, rideshare operators, and autonomous vehicle companies across the U.S., and serves the EV commercial segment by deploying fleet-charging solutions for light-duty EV fleets at depot locations, off-site charging hubs, or through its public network. It also owns PlugShare, a platform for EV drivers to locate public charging stations, plan trips and share charging experiences, which also provides charging location data licensing, infrastructure analysis, and EV driver research. It also derives revenue from the sale of regulatory credits earned from participation in LCFS programs and other carbon or emissions trading schemes in the U.S.